Skip to content
  • Solutions
    Solutions
    • Overview
    • TrypsiNNex®
      • TrypsiNNex® applications
      • TrypsiNNex® FAQ
    • Recombinant Insulin
      • Insulin applications
      • Insulin FAQ
      • Insulin 10 reasons why
    • Benzalkonium Chloride (BKC)
      • BKC applications
      • BKC FAQ
      • BKC 10 reasons why
    • Product list
  • Resources
    Resources
    • Overview
    • TrypsiNNex® insights
      • Application notes
      • Webinars and videos
      • Posters and infographics
    • Insulin insights
      • Application notes and case studies
      • Posters and infographics
      • Webinars and presentations
      • E-book
      • Insulin learnings
    • BKC insights
      • Whitepapers
      • Webinars and videos
      • BKC learnings
      • Scientific resources
    • SDS documents
      • TrypsiNNex®
      • Recombinant Insulin
      • Benzalkonium Chloride 
  • Company
    • Overview
    • About us
      • We are enablers
      • Values
      • Management
      • Board of Directors
    • Collaboration
    • Valuechain
      • Annual report 2024
  • Career
  • Sustainability
    • Overview
    • Environment
    • Social
    • Governance
  • Contact
    Contact
    • Overview
    • Let’s get in touch
    • Request sample​
    • Request quotation
    • Distributors and agents
  • Search
    Filter by content type
    Choose One/Select all
    Taxonomy terms

    Try these: Benzalkonium ChlorideRecombinant InsulinTrypsiNNexInsightsSDS documentsCase StudyWhite paper

nnp_web-logo_large
Menu
  • Solutions
    • Overview
    • TrypsiNNex®
      •  TrypsiNNex®
      • TrypsiNNex® FAQ
      • TrypsiNNex® applications
    • Recombinant Insulin
      • Recombinant Insulin
      • Insulin applications
      • Insulin FAQ
      • Insulin 10 reasons why
    • Benzalkonium Chloride
      • Benzalkonium Chloride (BKC)
      • BKC applications
      • BKC FAQ
      • BKC 10 reasons why
    • Products
  • Resources
    • Overview
    • Insulin insights
    • BKC insights
    • SDS Documents
  • Career
  • Company
    • Overview
    • About us
    • Collaboration
    • Management
    • Annual report
    • Values
    • Valuechain
  • Sustainability
    • Overview
    • Environment
    • Social
    • Governance
  • Contact
    • Overview
    • Let’s get in touch
    • Request sample​
    • Request quotation
    • Distributors and agents
  • Search

Category: related

Application note: Enhance your iPSC cultures with Recombinant Insulin

Pluripotent stem cells

Enhancing protein productivity in CHO-K1 using Recombinant Insulin in cell culture media

Monoclonal antibodies

Boosting protein productivity in CHO-S cells through cell culture media optimization

Monoclonal antibodies

Boosting AAV and LV viral vector production in HEK293 cells with Recombinant Insulin

Viral vectors for gene therapy

Boosting influenza virus production in HEK293 cells with Recombinant Insulin

Cell-based vaccinees

Boosting VLP production in Sf9 cells with Recombinant Insulin

Cell-based vaccinees

Enhancing iPSC culture quality with Recombinant Insulin supplementation

Pluripotent stem cells

Novo Nordisk Pharmatech

Københavnsvej 216
4600 Køge,
Denmark
+45 5667 1000
[email protected]

CVR-no. 13246149

Other links

  • News
  • Events
  • Let’s get in touch
  • Request sample​
  • Request quotation
  • MaxPartner platform
  • News
  • Events
  • Let’s get in touch
  • Request sample​
  • Request quotation
  • MaxPartner platform

Company

  • About us
  • Collaboration
  • Management
  • Valuechain
  • Values
  • Annual report 2024
  • About us
  • Collaboration
  • Management
  • Valuechain
  • Values
  • Annual report 2024
© 2025 Novo Nordisk Pharmatech A/S
  • General terms and conditions
  • Privacy policy
  • Cookie policy
  • General terms and conditions
  • Privacy policy
  • Cookie policy